kyvero
Market leaders

Pediatrix Medical Group, Inc. (MD)

Healthcare • Medical Care Facilities

StockNYSEUnited StatesUS58502B1061

31.40 USD -0.16% today Updated 13 Nov 2026 10:50

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Pediatrix Medical Group, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 10:50. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 18 Feb 2027 in 97 days · 08:00 · estimate 0.63
Last results 0.72 vs 0.65 estimated 29 Oct 2026 · Beat +10.8%
Beat the estimate 10 of 12 2 missed · 0 in line · 3 beats in a row
Average surprise +17.3% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

20 Feb 2024: estimate 0.32 20 Feb 2024: reported 0.32 02/24 07 May 2024: estimate 0.19 07 May 2024: reported 0.20 05/24 06 Aug 2024: estimate 0.31 06 Aug 2024: reported 0.34 08/24 01 Nov 2024: estimate 0.37 01 Nov 2024: reported 0.44 11/24 20 Feb 2025: estimate 0.36 20 Feb 2025: reported 0.51 02/25 06 May 2025: estimate 0.24 06 May 2025: reported 0.33 05/25 05 Aug 2025: estimate 0.42 05 Aug 2025: reported 0.53 08/25 03 Nov 2025: estimate 0.47 03 Nov 2025: reported 0.67 11/25 19 Feb 2026: estimate 0.54 19 Feb 2026: reported 0.50 02/26 05 May 2026: estimate 0.38 05 May 2026: reported 0.44 05/26 04 Aug 2026: estimate 0.59 04 Aug 2026: reported 0.63 08/26 29 Oct 2026: estimate 0.65 29 Oct 2026: reported 0.72 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
18 Feb 2027 08:00 0.63 — — Upcoming
29 Oct 2026 06:00 0.65 0.72 +10.8% Beat
04 Aug 2026 06:00 0.59 0.63 +6.6% Beat
05 May 2026 06:00 0.38 0.44 +16.1% Beat
19 Feb 2026 06:00 0.54 0.50 -7.1% Miss
03 Nov 2025 06:00 0.47 0.67 +43.9% Beat
05 Aug 2025 06:00 0.42 0.53 +24.9% Beat
06 May 2025 06:00 0.24 0.33 +36.7% Beat
20 Feb 2025 06:00 0.36 0.51 +39.9% Beat
01 Nov 2024 06:00 0.37 0.44 +19.7% Beat
06 Aug 2024 06:00 0.31 0.34 +11.1% Beat
07 May 2024 06:00 0.19 0.20 +5.9% Beat
20 Feb 2024 06:00 0.32 0.32 -1.4% Miss
02 Nov 2023 07:00 0.43 0.32 -26.0% Miss
03 Aug 2023 06:00 0.40 0.39 -3.1% Miss
02 May 2023 06:00 0.22 0.23 +3.8% Beat
17 Feb 2023 06:00 0.49 0.47 -4.2% Miss
03 Nov 2022 06:00 0.54 0.40 -26.3% Miss
04 Aug 2022 06:00 0.47 0.47 -0.5% In line
28 Apr 2022 06:00 0.27 0.33 +20.9% Beat
17 Feb 2022 06:00 0.43 0.52 +22.0% Beat
28 Oct 2021 06:00 0.41 0.46 +11.6% Beat
06 Aug 2021 06:00 0.32 0.41 +27.2% Beat
07 May 2021 06:00 0.14 0.24 +76.3% Beat
18 Feb 2021 06:00 0.36 0.25 -30.2% Miss
06 Nov 2020 06:00 0.40 0.37 -6.5% Miss
30 Jul 2020 06:00 0.12 0.32 +167.1% Beat
07 May 2020 07:00 0.54 0.32 -40.7% Miss
20 Feb 2020 06:00 0.90 0.91 +1.0% Beat
01 Nov 2019 06:00 0.91 0.91 +0.2% In line
01 Aug 2019 06:00 0.86 0.89 +3.2% Beat
02 May 2019 06:00 0.71 0.71 +0.4% In line
07 Feb 2019 06:00 0.91 0.92 +1.5% Beat
01 Nov 2018 06:00 0.97 0.94 -3.2% Miss
02 Aug 2018 06:00 1.07 1.07 +0.3% In line
30 Apr 2018 18:00 0.86 0.89 +3.1% Beat
08 Feb 2018 06:00 0.83 0.87 +4.5% Beat
01 Nov 2017 06:00 0.84 0.87 +3.0% Beat
28 Jul 2017 06:00 0.87 0.85 -2.6% Miss
04 May 2017 06:00 0.75 0.75 0.0% In line
07 Feb 2017 06:00 1.06 1.00 -5.3% Miss
27 Oct 2016 06:00 1.11 1.09 -1.5% Miss
28 Jul 2016 06:00 1.07 1.03 -3.6% Miss
28 Apr 2016 06:00 0.87 0.87 -0.2% In line
04 Feb 2016 06:00 1.12 1.13 +1.3% Beat
29 Oct 2015 06:00 1.07 1.10 +2.7% Beat
30 Jul 2015 06:00 0.88 0.90 +1.9% Beat
30 Apr 2015 06:00 0.71 0.72 +1.8% Beat
29 Jan 2015 06:00 0.86 0.89 +3.3% Beat
30 Oct 2014 06:00 0.85 0.86 +1.1% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 1.9B -4.9% 165.4M 8.6% 1.94 +263.0% 252.6M
2024 2B +0.9% -99.1M -4.9% -1.19 -63.0% 184.6M
2023 2B +1.1% -60.4M -3.0% -0.73 -192.4% 104M
2022 2B — 66.3M 3.4% 0.79 — 137.2M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
12 Nov 2026 31.70 31.96 31.09 31.40 -0.16% 376,900
11 Nov 2026 30.82 31.48 30.24 31.45 -0.54% 931,900
10 Nov 2026 31.48 31.69 30.84 31.62 +0.41% 536,400
09 Nov 2026 31.76 31.88 31.27 31.49 +0.64% 416,600
06 Nov 2026 31.01 31.52 30.84 31.29 -1.73% 491,300
05 Nov 2026 33.28 33.74 31.50 31.84 -2.93% 905,900
04 Nov 2026 31.41 33.43 31.01 32.80 +7.19% 1,185,300
03 Nov 2026 30.44 30.95 29.75 30.60 -0.36% 1,180,100
02 Nov 2026 30.11 31.07 29.61 30.71 +2.98% 1,171,000
30 Oct 2026 29.48 29.97 29.07 29.82 +2.19% 1,114,300
1,249 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
31.45 USD
Market cap
2.5B
Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 12.5 / 25
  • Revenue growth of -1.0% a year
  • Earnings per share growth of 34.9% a year
Quality Return on equity, net margin and how stable the margins are. 11.1 / 25
  • ROE of 17%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 18.4 / 20
  • Net debt is 0.7× EBITDA
  • Free cash flow yield of 5.8%
Valuation Free cash flow yield and the P/E against its sector. 14.7 / 15
  • P/E 17.2 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 1.9 / 10
  • Analysts' target is -4% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 17.16× Fair 30.56×
P/E (forward) 12.52× Good 14.16×
Price / book 2.81× Fair 3.5×
Price / sales 1.25× Good 3.33×
EV / EBITDA 9.85× Good 11.19×
Free cash flow yield 5.8% Good 2.1%
Quality
FigureValueReading Sector median
Gross margin 26.1% Fair 54.9%
Operating margin 12.1% Fair 5.8%
Net margin 7.7% Fair 1.2%
Return on equity 17.2% Good 4.4%
Return on assets 6.9% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year -1% Weak 10.1%
EPS growth / year 34.9% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.72× Good 0.4×
Net debt / EBITDA 0.71× Good 1.46×
Interest cover 6.43× Fair 2.17×
Current ratio 1.28× Fair 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow MD and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in